CSG's 60% Rout: A Legal Quagmire Overshadows a €17 Billion Backlog and Unanimous Buy Ratings

The disconnect at the Czechoslovak Group (CSG) could hardly be more pronounced. While the defence contractor runs its factories at full tilt, churns out record orders and secures critical supply chains, its stock has been pulverised. On Tuesday, shares slid another 3.63 percent to €14.24, inching ever closer to the all-time low of €13.65 struck in May. Since the January peak, the Amsterdam-listed equity has surrendered roughly 60 percent of its value.

Operationally, the story could not be more different. In the first quarter, CSG generated revenue of €1.54 billion, while operating profit climbed to €372 million. The order book swelled to a colossal €17 billion. Management has reaffirmed its full-year guidance, targeting up to €7.6 billion in turnover and an operating margin of around 25 percent. Yet the market yawns – the stock trades at less than half the average analyst target of €32, a level all ten covering analysts consider a buy.

The culprit is a bitter legal war with minority shareholder Petr Kratochvíl. He holds stakes in two key subsidiaries and is demanding roughly 35 billion Czech koruna (€1.4 billion) for his exit. Majority owner Michal Strnad counters with just four billion koruna. Courts in the Czech Republic and Slovakia are now involved, injecting uncertainty that institutional investors abhor. The fear of spiralling legal costs and an unstable ownership structure has overwhelmed any positive operational news.

The technical damage is severe. The relative strength index has fallen to 28, flagging a deeply oversold condition, while share-price volatility stands at an extreme 77 percent. UBS has already acted: in early June, the bank issued millions of put warrants on CSG, allowing traders to bet on further downside. Short-sellers are circling, and the regular flow of negative headlines around the shareholder dispute keeps the pressure on.

Should investors sell immediately? Or is it worth buying CSG?

Meanwhile, CSG is quietly fortifying its supply chain. It now holds roughly 20 percent of voting rights in Germany's Alzchem Group – either through direct shares or financial instruments – ensuring access to critical chemicals used in ammunition production. The primary source puts the stake at "knapp zehn Prozent der Stimmrechte" (just under 10 percent), while the secondary source says "rund 20 Prozent der Stimmrechte". Since both articles are from different dates, I need to reconcile. The primary article likely has older data; the secondary is more recent (mentions Tuesday drop, etc.). So use the more recent figure: approximately 20 percent.

The production ramp-up is equally ambitious. Since the start of June, CSG has been manufacturing artillery shells in Ukraine together with Ukrainian Armor, targeting 100,000 NATO-standard rounds per year. The broader aim is to boost total output to 850,000 units annually by the end of 2026. A new line in Slovakia is already running at full capacity. In Poland, CSG Polska is negotiating a partnership with state-owned PGZ to build engines for heavy off-road vehicles, serving both military and civilian markets.

On the strategic front, CSG has set its sights on a stake in Franco-German tank builder KNDS. But the owning families have rebuffed the approach, preferring an IPO in July or a state-backed entry by the German government. That stalemate adds another layer of uncertainty.

CSG at a turning point? This analysis reveals what investors need to know now.

The next major test arrives on 7 August 2026, when CSG reports its first-half results. That date will present management with a platform to demonstrate that operational momentum can outweigh the legal deadweight. Until then, the shareholder feud – not the record order book – will continue to dictate the share price trajectory. If the selling pressure persists, a break below €13.65 looms as the next grim milestone.

Ad

CSG Stock: New Analysis - 9 June

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSGS | boerse | 69509488 |